Skip to content

Clinical trials

Phase 2/3 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2/3 Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20061
20074
20083
20094
20101
20121
20133
20143
20155
20161
20181
20198
20202
20214
20225
20235
20243
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status26
Completed10
Recruiting10
Terminated6
Not yet recruiting5
Withdrawn5
Active, not recruiting3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangxi Medical University6
Eastern Hepatobiliary Surgery Hospital4
All India Institute of Medical Sciences3
Shanghai Zhongshan Hospital3
Federation Francophone de Cancerologie Digestive2
Fudan University2
RenJi Hospital2
Sun Yat-sen University2
Zhejiang Cancer Hospital2
Zhongda Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular67
Liver Neoplasms10
Fibrosis2
Hepatitis B2
Neoplasm Metastasis2
Pancreatic Neoplasms2
Recurrence2
Adenocarcinoma1
Bites and Stings1
Breast Neoplasms1

Trials

Showing 76 to 67 of 67. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.